JP2015518478A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518478A5
JP2015518478A5 JP2015504970A JP2015504970A JP2015518478A5 JP 2015518478 A5 JP2015518478 A5 JP 2015518478A5 JP 2015504970 A JP2015504970 A JP 2015504970A JP 2015504970 A JP2015504970 A JP 2015504970A JP 2015518478 A5 JP2015518478 A5 JP 2015518478A5
Authority
JP
Japan
Prior art keywords
cations
optionally
grafted
pos
chelating agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015504970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518478A (ja
JP6368301B2 (ja
Filing date
Publication date
Priority claimed from FR1253438A external-priority patent/FR2989280B1/fr
Application filed filed Critical
Publication of JP2015518478A publication Critical patent/JP2015518478A/ja
Publication of JP2015518478A5 publication Critical patent/JP2015518478A5/ja
Application granted granted Critical
Publication of JP6368301B2 publication Critical patent/JP6368301B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015504970A 2012-04-13 2013-04-12 マルチモーダル造影剤としての超微細ナノ粒子 Active JP6368301B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1253438 2012-04-13
FR1253438A FR2989280B1 (fr) 2012-04-13 2012-04-13 Nanoparticules ultrafines comme agent de contraste multimodal
PCT/EP2013/057677 WO2013153197A1 (fr) 2012-04-13 2013-04-12 Nanoparticules ultrafines comme agent de contraste multimodal

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016253238A Division JP6385420B2 (ja) 2012-04-13 2016-12-27 マルチモーダル造影剤としての超微細ナノ粒子

Publications (3)

Publication Number Publication Date
JP2015518478A JP2015518478A (ja) 2015-07-02
JP2015518478A5 true JP2015518478A5 (cg-RX-API-DMAC7.html) 2017-02-23
JP6368301B2 JP6368301B2 (ja) 2018-08-01

Family

ID=48170443

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015504970A Active JP6368301B2 (ja) 2012-04-13 2013-04-12 マルチモーダル造影剤としての超微細ナノ粒子
JP2016253238A Active JP6385420B2 (ja) 2012-04-13 2016-12-27 マルチモーダル造影剤としての超微細ナノ粒子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016253238A Active JP6385420B2 (ja) 2012-04-13 2016-12-27 マルチモーダル造影剤としての超微細ナノ粒子

Country Status (8)

Country Link
US (2) US10517962B2 (cg-RX-API-DMAC7.html)
EP (2) EP2836237B1 (cg-RX-API-DMAC7.html)
JP (2) JP6368301B2 (cg-RX-API-DMAC7.html)
CA (1) CA2869689C (cg-RX-API-DMAC7.html)
DK (1) DK2836237T3 (cg-RX-API-DMAC7.html)
ES (1) ES2791224T3 (cg-RX-API-DMAC7.html)
FR (1) FR2989280B1 (cg-RX-API-DMAC7.html)
WO (1) WO2013153197A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3192530A1 (fr) * 2016-01-15 2017-07-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nanoparticules ultrafines comme agent d'imagerie pour el diagnostic d'une dysfonction rénale
US11590225B2 (en) 2016-12-08 2023-02-28 The Brigham And Women's Hospital, Inc. Bismuth-gadolinium nanoparticles
US11512003B2 (en) * 2017-06-09 2022-11-29 Nh Theraguix Method for synthesizing silica nanoparticles
FR3072281B1 (fr) 2017-10-13 2020-12-04 Nh Theraguix Nanovecteurs et utilisations, en particulier pour le traitement de tumeurs
FR3075649A1 (fr) * 2017-12-22 2019-06-28 Mexbrain Dispositif pour le maintien de l'homeostasie metallique, et ses utilisations
CN114025808A (zh) * 2019-06-14 2022-02-08 高级催化剂应用品有限公司 通过放射性微粒的瘤内沉积治疗癌症的方法
FR3099883A1 (fr) * 2019-08-14 2021-02-19 Nh Theraguix Nanoparticules pour le traitement du cancer par rayonnement de radiofréquence
DE102019128842A1 (de) * 2019-10-25 2021-04-29 Universität Hamburg Verfahren, Vorrichtung und Markersubstanz-Kit zur multiparametrischen Röntgenfluoreszenz-Bildgebung
IT202000001048A1 (it) 2020-01-21 2021-07-21 Univ Degli Studi Padova Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici.
JP7479606B2 (ja) * 2020-05-19 2024-05-09 国立研究開発法人産業技術総合研究所 放射性組成物の製造方法
IT202100001049A1 (it) 2021-01-21 2022-07-21 Univ Degli Studi Padova Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795412B1 (fr) 1999-06-23 2001-07-13 Adir Nouveaux derives d'ammonium quaternaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4657721B2 (ja) 2002-09-19 2011-03-23 センター ナショナル デ ラ レシェルシェ サイエンティフィック(シーエヌアールエス) 新規な誘導システムの合成及び特徴付け、並びに標的細胞への治療対象分子のベクター化
FR2867180B1 (fr) 2004-03-02 2006-06-16 Univ Claude Bernard Lyon Nanoparticules hybrides comprenant un coeur de ln203 porteuses de ligands biologiques et leur procede de preparation
EP2330208B1 (en) 2004-05-24 2017-10-18 Midatech Ltd. Nanoparticles comprising RNA ligands
US20090317335A1 (en) * 2006-04-20 2009-12-24 Wenbin Lin Hybrid Nanomaterials as Multimodal Imaging Contrast Agents
FR2922106B1 (fr) 2007-10-16 2011-07-01 Univ Claude Bernard Lyon Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants.
US20110077506A1 (en) * 2008-04-17 2011-03-31 Bastiaan Driehuys Methods and compositions for molecular imaging
FR2959502B1 (fr) * 2010-04-30 2012-09-07 Nanoh Nanoparticules ultrafines a matrice polyorganosiloxane fonctionnalisee et incluant des complexes metalliques ; leur procede d'obtention et leurs applications en imagerie medicale et/ou therapie
US8688121B2 (en) 2010-04-30 2014-04-01 Blackberry Limited UE handling of common configuration after handover

Similar Documents

Publication Publication Date Title
JP2015518478A5 (cg-RX-API-DMAC7.html)
Ma et al. Recent advances in luminescent heavy metal complexes for sensing
Maldonado et al. Nano-functionalization of metal complexes for molecular imaging and anticancer therapy
Shibu et al. Nanomaterials formulations for photothermal and photodynamic therapy of cancer
WO2009097319A3 (en) Water-soluble nanocrystals through dual-interaction ligands
JP2011526312A5 (cg-RX-API-DMAC7.html)
JP2011509921A5 (cg-RX-API-DMAC7.html)
Browne et al. Nuclear data sheets for a= 251–259 (Odd)
JP2011525899A5 (cg-RX-API-DMAC7.html)
JP2014047406A5 (cg-RX-API-DMAC7.html)
JP2015512855A5 (cg-RX-API-DMAC7.html)
WO2012050810A3 (en) Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging
FR2933087B1 (fr) Suspension colloidale generatrice d'hydrogene.
JP2015522683A5 (cg-RX-API-DMAC7.html)
JP2009504909A5 (cg-RX-API-DMAC7.html)
JP2013531183A5 (cg-RX-API-DMAC7.html)
WO2009013358A3 (en) Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
AR074747A1 (es) Mejoras relacionadas con composiciones para el tratamiento de telas
JP2008280345A5 (cg-RX-API-DMAC7.html)
RU2019143780A (ru) Наночастица, содержащее ее контрастное вещество для магнитно-резонансной томографии и лигандное соединение
Ferguson Flat pencils of symplectic connections and Hamiltonian operators of degree 2
WO2012082612A3 (en) Metal nanoparticles with a pre-selected number of atoms
MX2017013705A (es) Nanocompuestos de grafeno-metales y oxidos de metales de transicion y metodos de manufactura.
TW200637938A (en) Method for forming metal nano/micro-wires
Kim et al. Phase Transition of Confined Gold Nanoparticles: Replica Exchange Molecular Dynamics Study